Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 74.83T 70.01T 64.09T 1L 83.58L 1L 8L 3L 41.98L 3L 3L 1.39Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 34Cr 232.7Cr 91Cr 1.18TCr 92Cr 90Cr 3.91TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.94%+4.82%+78.35%+126.30% 1,11900Cr
+1.33%+4.16%+53.18%+65.54% 65TCr
-0.04%+5.51%+27.26%+80.13% 47TCr
-1.38%+4.02%+42.52%+42.38% 37TCr
-0.52%+2.72%+25.21%+41.06% 30TCr
-1.06%+4.76%+2.00%+12.65% 26TCr
+0.45%+5.13%+52.84%+71.81% 24TCr
-0.53%+2.34%-18.53%-53.66% 21TCr
-0.01%+4.94%+27.71%+90.99% 18TCr
Average -0.29%+4.65%+32.28%+53.02% 38TCr
Weighted average by Cap. -0.31%+5.40%+45.48%+72.49%

Financials

2016 2017
Net sales 5.43Cr 4.65Cr 4.35Cr 3.98Cr 7.47Cr 519.25Cr 7.57Cr 51Cr 20Cr 260.84Cr 20Cr 20Cr 862.76Cr 11Cr 9.08Cr 8.49Cr 7.77Cr 15Cr 1.01TCr 15Cr 100.33Cr 39Cr 509.22Cr 40Cr 39Cr 1.68TCr
Net income -10Cr -8.82Cr -8.25Cr -7.56Cr -14Cr -985.29Cr -14Cr -98Cr -38Cr -494.95Cr -39Cr -38Cr -1.64TCr -13Cr -11Cr -10Cr -9.19Cr -17Cr -1.2TCr -17Cr -118.56Cr -46Cr -601.79Cr -47Cr -46Cr -1.99TCr
Net Debt 21Cr 18Cr 17Cr 15Cr 29Cr 2TCr 29Cr 198.38Cr 77Cr 1.01TCr 79Cr 77Cr 3.33TCr 25Cr 21Cr 20Cr 18Cr 34Cr 2.35TCr 34Cr 232.62Cr 91Cr 1.18TCr 92Cr 90Cr 3.91TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock